Redsense Medical AB

Redsense Medical AB

REDS · ST · Healthcare / Medical Devices

3.17SEK-0.13 (-3.94%)

Price History

Full chart

Market Stats

Previous Close3.30
Open3.35
Day Range3.17 – 3.52
52-Week Range2.40 – 5.70
Volume17.89K
Market Cap56.41M
P/E (TTM)0.00
Forward P/E909.09
EPS-0.23
Dividend Yield0.00%
Beta0.45
50-Day Avg3.53
200-Day Avg3.68

About

Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2000 and is headquartered in Halmstad, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Sebastien Bollue
  • Employees4
  • HeadquartersStorgatan 36, Halmstad, Sweden, 302 43, Sweden
  • Websitehttps://redsensemedical.com

Leadership

  • Mr. Sebastien BollueChief Executive Officer
  • Mr. Peter LarssonChief Financial Officer · b. 1969
  • Ms. Ann-Marie ErikssonChief Technology Officer

Financials

Income Statement

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-14.44M9.36M14.34M24.97M28.18M24.02M
Growth (%)---35.17%+53.17%+74.11%+12.85%-14.74%
Cost of Revenue-4.48M-1.04M3.08M11.84M10.10M8.46M
Gross Profit-9.96M10.40M11.26M13.13M18.08M15.56M
Gross Margin-68.95%111.08%78.55%52.58%64.15%64.78%
Operating Expense-18.08M22.39M21.47M18.20M17.87M22.93M
Operating Income--8.12M-11.99M-10.21M-5.07M209.00K-7.37M
Operating Margin--56.26%-128.08%-71.19%-20.29%0.74%-30.66%
EBITDA----8.60M-4.42M444.00K-6.50M
EBITDA Margin----59.99%-17.70%1.58%-27.07%
Net Income--9.03M-7.97M-8.76M-4.51M342.00K-7.17M
Net Income Margin--62.56%-85.15%-61.07%-18.08%1.21%-29.85%
Interest Expense-38.30K51.00K102.00K33.00K36.00K32.00K
Interest Expense % of Total Revenue-0.27%0.54%0.71%0.13%0.13%0.13%

Balance Sheet

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-78.70M43.25M30.73M26.50M41.80M39.26M
Total Liabilities-5.51M5.76M3.58M3.41M2.21M4.97M
Total Equity-73.20M37.49M27.15M23.09M39.58M34.28M
Cash-29.01M4.98M3.67M6.97M15.36M7.36M

Cash Flow

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-17.23M-12.22M-9.78M-5.05M-8.23M-5.20M
Capital Expenditure037.08M9.22M2.46M603.00K611.00K2.81M
Free Cash Flow--19.85M-21.44M-12.24M-5.66M-8.84M-8.01M
FCF to OCF--115.18%175.42%125.16%111.94%107.42%154.14%

Earnings

Report DateNov 18, 2019Feb 25, 2020May 4, 2020Aug 24, 2020Nov 9, 2020Feb 22, 2021May 3, 2021Aug 24, 2021Nov 9, 2021Feb 28, 2022May 2, 2022Aug 29, 2022Nov 9, 2022Feb 27, 2023May 9, 2023Aug 29, 2023Nov 9, 2023Feb 27, 2024May 8, 2024Aug 29, 2024Nov 26, 2024Feb 26, 2025May 28, 2025Aug 20, 2025Nov 19, 2025Dec 31, 2025May 26, 2026Jun 30, 2026
EPS Estimate----------------------------
EPS Actual-0.05-0.090.020.01-0.30-0.33-0.07-0.27-0.18-0.07-0.11-0.15-0.17-0.160.03-0.21-0.07-0.07-0.190.04-0.200.34-0.19-0.11-0.02-0.110.070.03
Surprise----------------------------
TimingAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap56.41M
Enterprise Value51.79M
Trailing P/E0.00
Forward P/E909.09
Price / Sales2.13
Price / Book1.62
EPS-0.23
Book Value2.17
Revenue (TTM)26.46M
Gross Profit (TTM)16.36M
EBITDA-66.00K
Profit Margin-2.45%
Operating Margin4.26%
Return on Equity-1.81%
Return on Assets-1.29%
Shares Outstanding16.44M
Shares Float7.77M
Beta0.45
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%